The trademark NUPROLIN was filed by Biopeutics Co., Ltd, a corporation established under the laws of the Cayman Islands (the "Applicant"). The application was published for oppositions on April 25, 2022, and received one opposition filed on July 21, 2022 by Genentech, Inc. on Likelihood of confusion. the opponent was represented by GEVERS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 21, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).